Information Security Lead, Cellares
$90-210k
Offers stock options
Cell therapy manufacturing services provider
Be an early applicant
Cell therapy manufacturing services provider
201-500 employees
Be an early applicant
$90-210k
Offers stock options
201-500 employees
Company mission
To accelrete access to life-saving cell therapies.
Role
Who you are
- Bachelors in Computer Science, or related field
- 8+ years of progressive information security experience with at least 2 years in a lead or senior individual contributor role
- Strong hands-on experience with SIEM tools (e.g., Splunk, Sentinel), EDR platforms, and vulnerability management tools (e.g., Tenable, Qualys)
- Deep knowledge of cloud security architecture (AWS, Azure, or GCP) and cloud-native security tools
- Experience driving SOC 2, ISO 27001, or NIST CSF compliance programs
- Proficiency in scripting and automation (Python, Bash, or PowerShell) for security tooling and response
- Excellent communication and stakeholder management skills — capable of translating technical risk into business language
- Self-awareness, integrity, authenticity, and a growth/entrepreneurial mindset
What the job involves
- We are seeking an Information Security Lead who will serve as the founding security hire and the anchor of Cellares' InfoSec program. This is a hands-on leadership role that blends strategic program development with direct technical execution
- The primary focus of this position will be to build and mature the company's security posture, lead a growing team across geographies, and ensure compliance with relevant regulatory frameworks including 21 CFR Part 11, SOC 2, and ISO 27001
- This is a multidisciplinary role & this individual will further interface across many parts of the company to drive policy and governance. Candidates should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows
- Design, build, and continuously improve Cellares' Information Security program from the ground up, including policies, standards, and procedures
- Develop and maintain a multi-year rolling strategic roadmap aligned to business objectives
- Lead day-to-day security operations, working closely with the India-based Security Analysts on monitoring, incident response, and vulnerability management
- Architect and maintain a cloud security framework across AWS, Azure, or GCP environments used by Cellares
- Own the security aspects of the software development lifecycle (SDLC), including threat modeling, secure code review, and developer security training
- Drive compliance efforts for SOC 2 Type II, ISO 27001, and life sciences-specific frameworks (e.g., 21 CFR Part 11, GxP)
- Conduct and manage third-party risk assessments, vendor security reviews, and penetration testing engagements
- Collaborate with IT, Engineering, Legal, and Operations to integrate security into all business processes
- Manage and mentor the India-based Security Analysts, providing technical guidance, career development, and task prioritization
- Lead incident response activities, conduct post-mortems, and implement lessons-learned improvements
- Report on security metrics, risks, and program maturity to executive stakeholders
Our take
There is a significant need for efficient, scalable manufacturing of cell therapies in the biopharmaceutical industry. As demand for advanced treatments like CAR T-cell therapies rises, traditional manufacturing methods often struggle with scalability, high costs, and process failures, limiting patients' access to these lifesaving therapies.
In response, Cellares has developed the CEll Shuttle platform, an automated system designed for high-throughput cell therapy production. The Cell Shuttle can manufacture 16 batches simultaneously, cutting batch costs by up to 50%. By integrating advanced technologies for flow cytometry and cell sorting, Cellares enhances operational efficiency, providing comprehensive solutions that accelerate access to therapies.
Partnering with industry leaders like Kite, Bristol Myers Squibb, and Cabeletta Bio further strengthens its market position, showcasing the platform's potential impact. Along with over $600M in funding and a commercial-scale facility in New Jersey, Cellares is well-prepared to scale operations and meet global demand, positioning itself for future growth in the evolving cell therapy landscape.
Steph
Company Specialist at Welcome to the Jungle
Insights
44% employee growth in 12 months
Company
Funding (last 2 of 4 rounds)
Jan 2026
$257m
SERIES D
Aug 2023
$255m
SERIES C
Total funding: $612m
Company benefits
- Holidays & Flexible Vacation
- Parental Leave
- Comprehensive Healthcare
- 401k + Company Match
- Catered Onsite Meals
- Premium Technology
- EV Charging
- Professional Development
Company HQ
The East Side, South San Francisco, CA
Leadership
Fabian Gerlinghaus
(Co-Founder & CEO)Graduated from the University of Munich with a Master's Degree in Aerospace Engineering. Prior to co-founding Cellares in 2019, they were the CHief Innovation officer at Synthego.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 7 more jobs at Cellares